TGA okays first anti-amyloid Alzheimer’s drug

4 minute read


The intravenous infusion, which is yet to be considered for the PBS, will likely be restricted to tertiary facilities. Is the healthcare system ready, though?


The intravenous infusion, which is yet to be considered for the PBS, will likely be restricted to tertiary facilities. Is the healthcare system ready, though?

This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.

End of content

No more pages to load

Log In Register ×